Inhibition of DNA methyltransferase activity upregulates Fyn tyrosine kinase expression in Hut-78 T-lymphoma cells

被引:4
作者
Kozlowska, A. [1 ]
Jagodzinski, P. P. [1 ]
机构
[1] Karol Marcinkowski Univ Med Sci, Dept Biochem & Mol Biol, PL-60781 Poznan, Poland
关键词
T-lymphoma; Fyn tyrosine kinase; Epigenetics;
D O I
10.1016/j.biopha.2008.01.011
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tyrosine kinase Fyn, the expression of which is epigenetically regulated, has been proposed to be a tumour suppressor gene. A frequent deletion at the 6q chromosomal region encoding the Fyn gene in lymphomas has been reported. Therefore, we assessed the impact of 5-Aza-2'-deoxycytidine (5-dAzaC), a DNA methyltransferase (DNMTs) inhibitor on Fyn expression in Hut-78 T-lymphoma cells. Using reverse transcription, real-time quantitative PCR (RQ-PCR), and western blot analyses, we found that 5-dAzaC significantly increased transcript and protein levels of Fyn in Hut-78 T-lymphoma cells. However, bisulfite sequencing revealed that Hut-78 T-lymphoma cells cultured in the absence of 5-dAzaC contained unmethylated cytosine in the cytosine-guanosine dinucleotide island of the Fyn promoter. Our results suggest that the DNMTs activity may have an indirect influence on the expression of Fyn without altering the methylation level of its promoter in Hut-78 T-lymphoma cells. (c) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:672 / 676
页数:5
相关论文
共 35 条
[1]   Loss of heterozygosity on chromosome arms 3p and 6q in microdissected adenocarcinomas of the uterine cervix and adenocarcinoma in situ [J].
Acevedo, CM ;
Henríquez, M ;
Emmert-Buck, MR ;
Chuaqui, RF .
CANCER, 2002, 94 (03) :793-802
[2]   Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma [J].
Berwanger, B ;
Hartmann, O ;
Bergmann, E ;
Bernard, S ;
Nielsen, D ;
Krause, M ;
Kartal, A ;
Flynn, D ;
Wiedemeyer, R ;
Schwab, M ;
Schäfer, H ;
Christiansen, H ;
Eilers, M .
CANCER CELL, 2002, 2 (05) :377-386
[3]   Allelic gains and losses in distinct regions of chromosome 6 in gastric carcinoma [J].
Carvalho, B ;
van der Veen, AY ;
Gärtner, F ;
Carneiro, F ;
Seruca, R ;
Buys, CHCM ;
Kok, K .
CANCER GENETICS AND CYTOGENETICS, 2001, 131 (01) :54-59
[4]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[5]   NEGATIVE REGULATION OF T-CELL RECEPTOR SIGNALING BY TYROSINE PROTEIN-KINASE P50(CSK) [J].
CHOW, LML ;
FOURNEL, M ;
DAVIDSON, D ;
VEILLETTE, A .
NATURE, 1993, 365 (6442) :156-160
[6]  
DAVIDSON D, 1960, MOL CELL BIOL, V2007, P27
[7]   Fyn regulates the duration of TCR engagement needed for commitment to effector function [J].
Filby, Andrew ;
Seddon, Benedict ;
Kleczkowska, Joanna ;
Salmond, Robert ;
Tomlinson, Peter ;
Smida, Michal ;
Lindquist, Jonathan A. ;
Schraven, Burkhart ;
Zamoyska, Rose .
JOURNAL OF IMMUNOLOGY, 2007, 179 (07) :4635-4644
[8]   RETRACTED: 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal (Retracted Article) [J].
Ghoshal, K ;
Datta, J ;
Majumder, S ;
Bai, SM ;
Kutay, H ;
Motiwala, T ;
Jacob, ST .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (11) :4727-4741
[9]   DNA methylation as a therapeutic target in cancer [J].
Issa, Jean-Pierre J. .
CLINICAL CANCER RESEARCH, 2007, 13 (06) :1634-1637
[10]   Epigenetics in carcinogenesis and cancer prevention [J].
Jones, PA .
EPIGENETICS IN CANCER PREVENTION: EARLY DETECTION AND RISK ASSESSMENT, 2003, 983 :213-219